Triple-negative breast cancers (TNBCs) lack expression of oestrogen, progesterone, and Human Epidermal Growth Factor 2 receptors. The NEMESI study described current Italian treatment practices in patients with operable, early-stage breast cancer (EBC).Retrospective, observational study involving 63 Italian oncology centres. Eligible patients were aged ≥ 18 years with EBC (stage I-II) who had undergone surgery, received ≥ 1 cycle of adjuvant chemotherapy and/or adjuvant hormonal therapy and attended an oncology centre between 1 January 2008 and 30 June 2008. This subanalysis focused on patients with TNBC. Variables evaluated included: demographic data/clinical characteristics; tumour characteristics; adjuvant therapy; compliance to chemotherapy. Continuous variables were summarised using descriptive statistics.Of 1894 patients in the NEMESI study, 185 patients (9.8\%) had TNBC. At diagnosis, 98 patients were aged 50-70 years and 114 were post-menopausal. Tumours were subcategorised as pT1mic/pT1a/pT1b/pT1c in 108 patients and pT2/pT3/pT4b in 77 patients. Mean tumour size was 2.1cm, tumours were highly undifferentiated in 144 patients and 128 patients were pNO. 179 patients received adjuvant chemotherapy; anthracyclines with or without taxanes were commonly used. 145 patients received radiotherapy.Adherence of Italian clinical practice to International Guidelines in the management of early-stage TNBC is satisfactory.
|Data di pubblicazione:||2012|
|Titolo:||Management and treatment of triple-negative breast cancer patients from the NEMESI study: an Italian experience.|
|Autore/i:||V. Adamo;G. R. R;S. D. Placido;G. Colucci;P. Conte;D. Giuffrida;N. Gebbia;G. Masci;F. Cognetti;D. Dondi;M. Venturini|
|Digital Object Identifier (DOI):||10.1016/j.ejca.2011.06.028|
|Codice identificativo ISI:||WOS:000301849900002|
|Codice identificativo Scopus:||2-s2.0-84858705526|
|Citazione:||Management and treatment of triple-negative breast cancer patients from the NEMESI study: an Italian experience / V. Adamo;G. R. R;S. D. Placido;G. Colucci;P. Conte;D. Giuffrida;N. Gebbia;G. Masci;F. Cognetti;D. Dondi;M. Venturini. - In: EUROPEAN JOURNAL OF CANCER. - ISSN 0959-8049. - STAMPA. - 48(2012), pp. 642-647.|
|Tipologia||Articolo su rivista|
File in questo prodotto:
I documenti presenti in Iris Unimore sono rilasciati con licenza Creative Commons Attribuzione - Non commerciale - Non opere derivate 3.0 Italia, salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris